[
    {
        "id": "4713548",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2024-08-11T09:26:54-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2024 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4713548-adc-therapeutics-sa-2024-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4713547",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-08-11T09:26:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q2 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4713547-adc-therapeutics-sa-adct-q2-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4689794",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-05-06T11:04:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q1 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4689794-adc-therapeutics-sa-adct-q1-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4689752",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2024-05-06T08:56:08-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2024 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4689752-adc-therapeutics-sa-2024-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4677980",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-03-13T13:24:05-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4677980-adc-therapeutics-sa-adct-q4-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4677913",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2024-03-13T10:13:42-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2023 Q4 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4677913-adc-therapeutics-sa-2023-q4-results-earnings-call-presentation"
        }
    },
    {
        "id": "4648723",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-07T16:23:09-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q3 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4648723-adc-therapeutics-sa-adct-q3-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4625530",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-08-08T15:40:25-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q2 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4625530-adc-therapeutics-sa-adct-q2-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4625453",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-08-08T13:27:49-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2023 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4625453-adc-therapeutics-sa-2023-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4605124",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-05-16T13:48:22-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2023 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4605124-adc-therapeutics-sa-2023-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4601991",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-09T12:21:06-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q1 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4601991-adc-therapeutics-sa-adct-q1-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4589534",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-03-23T05:53:31-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics (ADCT) Presents At 44th Annual Institutional Investors Conference - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4589534-adc-therapeutics-adct-presents-44th-annual-institutional-investors-conference-slideshow"
        }
    },
    {
        "id": "4583086",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-02-28T19:20:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q4 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4583086-adc-therapeutics-sa-adct-q4-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4555110",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-11-08T21:19:03-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Q3 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4555110-adc-therapeutics-sa-adct-q3-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4531983",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-08-09T11:07:11-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Ameet Mallik on Q2 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4531983-adc-therapeutics-sa-adct-ceo-ameet-mallik-on-q2-2022-results-earnings-call-transcript"
        }
    },
    {
        "id": "4516492",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-06-04T11:33:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics (ADCT) Investor Presentation - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4516492-adc-therapeutics-adct-investor-presentation-slideshow"
        }
    },
    {
        "id": "4509119",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-05-09T12:21:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Ameet Mallik on Q1 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4509119-adc-therapeutics-sa-adct-ceo-ameet-mallik-on-q1-2022-results-earnings-call-transcript"
        }
    },
    {
        "id": "4509065",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-05-09T10:38:44-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2022 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4509065-adc-therapeutics-sa-2022-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4492714",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-03-03T15:05:04-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q4 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4492714-adc-therapeutics-sa-adct-ceo-christopher-martin-on-q4-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4492598",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-03-03T11:56:40-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2021 Q4 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4492598-adc-therapeutics-sa-2021-q4-results-earnings-call-presentation"
        }
    },
    {
        "id": "4486227",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-02-11T03:31:22-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Investor Presentation - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4486227-adc-therapeutics-sa-adct-investor-presentation-slideshow"
        }
    },
    {
        "id": "4466053",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-11-05T14:57:33-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2021 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4466053-adc-therapeutics-sa-2021-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "4464569",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-11-02T14:51:13-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q3 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4464569-adc-therapeutics-sa-adct-ceo-christopher-martin-on-q3-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4458076",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-10-01T15:44:38-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics (ADCT) Investor Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4458076-adc-therapeutics-adct-investor-presentation"
        }
    },
    {
        "id": "4446454",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-08-07T13:16:12-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q2 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4446454-adc-therapeutics-sa-adct-ceo-christopher-martin-on-q2-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4444321",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-08-03T10:59:22-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2021 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4444321-adc-therapeutics-sa-2021-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4428867",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-05-14T15:33:47-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) Investor Presentation - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4428867-adc-therapeutics-sa-adct-investor-presentation-slideshow"
        }
    },
    {
        "id": "4426270",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-05-09T01:57:30-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q1 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4426270-adc-therapeutics-sa-adct-ceo-christopher-martin-on-q1-2021-results-earnings-call-transcript"
        }
    },
    {
        "id": "4419313",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-04-15T18:08:21-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics (ADCT) Investor Presentation - Slideshow",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4419313-adc-therapeutics-adct-investor-presentation-slideshow"
        }
    },
    {
        "id": "4414819",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-03-18T13:54:43-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA 2020 Q4 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4414819-adc-therapeutics-sa-2020-q4-results-earnings-call-presentation"
        }
    },
    {
        "id": "4414825",
        "type": "transcript",
        "attributes": {
            "publishOn": "2021-03-18T13:12:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Chris Martin on Q4 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4414825-adc-therapeutics-sa-adct-ceo-chris-martin-on-q4-2020-results-earnings-call-transcript"
        }
    },
    {
        "id": "4388518",
        "type": "transcript",
        "attributes": {
            "publishOn": "2020-11-12T14:17:05-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics' (ADCT) CEO Chris Martin on Q3 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4388518-adc-therapeutics-adct-ceo-chris-martin-on-q3-2020-results-earnings-call-transcript"
        }
    },
    {
        "id": "4369596",
        "type": "transcript",
        "attributes": {
            "publishOn": "2020-08-18T20:48:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "ADC Therapeutics SA (ADCT) CEO Christopher Martin on Q2 2020 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "600175",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4369596-adc-therapeutics-sa-adct-ceo-christopher-martin-on-q2-2020-results-earnings-call-transcript"
        }
    }
]